On June 10, 2025 Kimberly Moore, PharmD MS Medical Outcomes Science Liaison at AbbVie joined Catalyst for Payment Reform to unpack the growing crisis of mental health in the American workforce—and what employers can do about it.

Moore, a pharmacist, researcher, and expert witness in community pharmacy litigation, draws on real-world experience and national data to break down the economic and human costs of two of the most prevalent and misunderstood mental health disorders: Major Depressive Disorder (MDD) and Bipolar I Disorder.

With more than 300 billion dollars in associated costs and nearly one in four workers silently struggling, this conversation makes a compelling case for why employers can no longer afford to treat mental health like a personal issue.

Key Insights:

💼 The price of silence: Three out of four employees have struggled with a mental health issue—but most never tell their employer. Kimberly shares how stigma, poor benefit design, and lack of access are keeping workers from getting care.

📉 Productivity’s hidden drain: From presenteeism and absenteeism to costly disability claims, MDD is driving an unsustainable rise in indirect costs—costs that often go unseen by employers until it’s too late.

🧠 Missed diagnoses, missed opportunities: MDD and Bipolar I are often misdiagnosed or undertreated. Learn how under-prescribing effective treatments—especially adjunctive therapies—leads to lost productivity, increased ER visits, and greater disability burden.

🧰 What employers can do now: Kimberly offers a roadmap for employers—from rethinking pharmacy benefits to strengthening mental health parity in their networks—so that employees aren’t left managing serious conditions alone.

Whether you’re an HR leader, health plan administrator, or just someone trying to make your workplace more humane, this episode is a vital look at the systems and strategies that can change the trajectory of mental health at work.

Fill out the form below to access the webinar: